Home New hydrazone derivatives: synthesis, characterization, carbonic anhydrase I-II enzyme inhibition, anticancer activity and in silico studies
Article
Licensed
Unlicensed Requires Authentication

New hydrazone derivatives: synthesis, characterization, carbonic anhydrase I-II enzyme inhibition, anticancer activity and in silico studies

  • Ulviye Acar Cevik ORCID logo EMAIL logo , Hakan Ünver , Hayrani Eren Bostancı , Burak Tüzün , Nurten İrem Gedik and Ümit M. Kocyigit
Published/Copyright: March 14, 2025
Become an author with De Gruyter Brill

Abstract

A new series of hydrazone derivatives (1a-1l) were prepared from a condensation reaction between different hydrazide derivatives and 3-formylbenzoic acid. Through the use of several spectral techniques, such as 1H-NMR, 13C-NMR, and elemental analysis, the structures of the compounds were clarified. The crystal structure of compound 1d was obtained by single-crystal X-ray crystallography. They were found to have inhibitory effects on the anticancer potentials and human carbonic anhydrase isoforms I and II. Compound 1d was found to be the strongest inhibitor, with IC50 values of 0.133 µM against hCA I. Also, compound 1l showed the highest inhibitory activity with IC50 values of 3.244 µM against hCA II. Moreover, their cytotoxic effects on rat glioma cell and colon adeno carcinoma cell lines were evaluated. According to the cytotoxicity results, compounds 1j and 1l exhibited the highest cytotoxicity on the HT29 cell, while compounds 1e, 1g, and 1l showed the strongest cytotoxic effect on C6 cell line. Compound 1l, which carries the methoxy substituent at the 3rd position on the phenyl ring, was effective against both cancer cells and showed the highest inhibitory effect on hCA II. The ADME/T properties and molecular docking of the molecules with the highest activity were examined.


Corresponding author: Ulviye Acar Cevik, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Türkiye, E-mail:

Acknowledgments

“The authors acknowledge to Scientific and Technological Research Application and Research Center, Sinop University, Turkey, for the use of the Bruker D8 QUEST diffractometer.”

  1. Research ethics: Not applicable.

  2. Informed consent: Not applicable.

  3. Author contributions: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by the authors. The synthesis and X-ray studies of the compounds were carried out by [Hakan Ünver[ and [Ulviye Acar Çevik]. Cytotoxicity test was performed by [Hayrani Eren Bostancı], carbonic anhydrase test was performed by [Nurten İrem Gedik], [Ümit M. Kocyigit]. Docking and ADME studies were also carried out by [Burak Tüzün]. All authors read and approved the final manuscript.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The author states no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Not applicable.

References

1. Angeli, A, Kartsev, V, Petrou, A, Lichitsky, B, Komogortsev, A, Pinteala, M, et al.. Pyrazolo [4, 3-c] pyridine sulfonamides as carbonic anhydrase ınhibitors: synthesis, biological and in silico studies. Pharmaceuticals 2022;15:316. https://doi.org/10.3390/ph15030316.Search in Google Scholar PubMed PubMed Central

2. Kumar, R, Kumar, A, Ram, S, Angeli, A, Bonardi, A, Nocentini, A, et al.. Novel benzenesulfonamide‐bearing pyrazoles and 1,2,4‐thiadiazoles as selective carbonic anhydrase inhibitors. Arch Pharm 2022;355:2100241. https://doi.org/10.1002/ardp.202100241.Search in Google Scholar PubMed

3. Küçükbay, H, Gönül, Z, Küçükbay, FZ, Tekin, Z, Angeli, A, Bartolucci, G, et al.. Synthesis of new 7‐amino‐3, 4‐dihydroquinolin‐2 (1H)-one-peptide derivatives and their carbonic anhydrase enzyme inhibition, antioxidant, and cytotoxic activities. Arch Pharm 2021;354:2100122. https://doi.org/10.1002/ardp.202100122.Search in Google Scholar PubMed

4. Kurt, BZ, Sonmez, F, Ozturk, D, Akdemir, A, Angeli, A, Supuran, CT. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies. Eur J Med Chem 2019;183:111702. https://doi.org/10.1016/j.ejmech.2019.111702.Search in Google Scholar PubMed

5. Elkamhawy, A, Woo, J, Nada, H, Angeli, A, Bedair, TM, Supuran, CT, et al.. Identification of novel and potent indole-based benzenesulfonamides as selective human carbonic anhydrase II inhibitors: design, synthesis, in vitro, and in silico studies. Int J Mol Sci 2022;23:2540. https://doi.org/10.3390/ijms23052540.Search in Google Scholar PubMed PubMed Central

6. Singh, P, Choli, A, Swain, B, Angeli, A, Sahoo, SK, Yaddanapudi, VM, et al.. Design and development of novel series of indole-3-sulfonamide ureido derivatives as selective carbonic anhydrase II inhibitors. Arch Pharm 2022;355:2100333. https://doi.org/10.1002/ardp.202100333.Search in Google Scholar PubMed

7. Tugrak, M, Gul, I, Bandow, K, Sakagam, H, Gulcin, I, Ozkay, Y, et al.. Synthesis and biological evaluation of some new mono Mannich bases with piperazines as possible anticancer agents and carbonic anhydrase inhibitors. Bioorg Chem 2019;90:103095. https://doi.org/10.1016/j.bioorg.2019.103095.Search in Google Scholar PubMed

8. Said, MF, George, RF, Petreni, A, Supuran, CT, Mohamed, NM. Synthesis, molecular modelling and QSAR study of new N-phenylacetamide-2-oxoindole benzensulfonamide conjugates as carbonic anhydrase inhibitors with antiproliferative activity. J Enzym Inhib Med Chem 2022;37:701–17. https://doi.org/10.1080/14756366.2022.2036137.Search in Google Scholar PubMed PubMed Central

9. Huentupil, Y, Peña, L, Novoa, N, Berrino, E, Arancibia, R, Supuran, CT. New sulfonamides containing organometallic-acylhydrazones: synthesis, characterisation and biological evaluation as inhibitors of human carbonic anhydrases. J Enzym Inhib Med Chem 2019;34:451–8. https://doi.org/10.1080/14756366.2018.1555156.Search in Google Scholar PubMed PubMed Central

10. Askin, S, Tahtaci, H, Türkeş, C, Demir, Y, Ece, A, Çiftçi, GA, et al.. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo [2,1-b] [1,3,4] thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors. Bioorg Chem 2021;113:105009. https://doi.org/10.1016/j.bioorg.2021.105009.Search in Google Scholar PubMed

11. Chu, N, Wang, Y, Jia, H, Han, J, Wang, X, Hou, Z. Design, synthesis and biological evaluation of new carbohydrate-based coumarin derivatives as selective carbonic anhydrase IX inhibitors via “click” reaction. Molecules 2022;27:5464. https://doi.org/10.3390/molecules27175464.Search in Google Scholar PubMed PubMed Central

12. Kucukoglu, K, Faydali, N, Bul, D, Nadaroglu, H, Sever, B, Altıntop, MD, et al.. Synthesis, in silico and in vitro evaluation of new 3,5-disubstituted-1,2,4-oxadiazole derivatives as carbonic anhydrase inhibitors and cytotoxic agents. J Mol Struct 2023;1276:134699. https://doi.org/10.1016/j.molstruc.2022.134699.Search in Google Scholar

13. Bilginer, S, Bardaweel, SK, Demir, Y, Gulcin, I, Kazaz, C. Synthesis, cytotoxicities, and carbonic anhydrase inhibition activities of pyrazoline–benzenesulfonamide derivatives harboring phenol/polyphenol moieties. Med Chem Res 2022;31:925–35. https://doi.org/10.1007/s00044-022-02893-z.Search in Google Scholar

14. Said, MA, Eldehna, WM, Nocentini, A, Fahim, SH, Bonardi, A, Elgazar, AA, et al.. Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: design, synthesis, and in vitro biological evaluation. Eur J Med Chem 2020;189:112019. https://doi.org/10.1016/j.ejmech.2019.112019.Search in Google Scholar PubMed

15. Çevik, UA, Osmaniye, D, Çavuşoğlu, BK, Sağlik, BN, Levent, S, Ilgin, S, et al.. Synthesis of novel benzimidazole–oxadiazole derivatives as potent anticancer activity. Med Chem Res 2019;28:2252–61. https://doi.org/10.1007/s00044-019-02451-0.Search in Google Scholar

16. Kucukoglu, K, Gul, HI, Taslimi, P, Gulcin, I, Supuran, CT. Investigation of inhibitory properties of some hydrazone compounds on hCA I, hCA II and AChE enzymes. Bioorg Chem 2019;86:316–21. https://doi.org/10.1016/j.bioorg.2019.02.008.Search in Google Scholar PubMed

17. Yamali, C, Sakagami, H, Satoh, K, Bandow, K, Uesawa, Y, Bua, S, et al.. Investigation of carbonic anhydrase inhibitory effects and cytotoxicities of pyrazole-based hybrids carrying hydrazone and zinc-binding benzenesulfonamide pharmacophores. Bioorg Chem 2022;127:105969. https://doi.org/10.1016/j.bioorg.2022.105969.Search in Google Scholar PubMed

18. Abdel-Mohsen, HT, Omar, MA, Petreni, A, Supuran, CT. Novel 2-substituted thioquinazoline-benzenesulfonamide derivatives as carbonic anhydrase inhibitors with potential anticancer activity. Arch Pharm 2022:e2200180. https://doi.org/10.1002/ardp.202200180.Search in Google Scholar PubMed

19. Nada, H, Elkamhawy, A, Abdellattif, MH, Angeli, A, Lee, CH, Supuran, CT, et al.. 4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies. J Enzym Inhib Med Chem 2022;37:994–1004. https://doi.org/10.1080/14756366.2022.2055553.Search in Google Scholar PubMed PubMed Central

20. Inam, A, Siddiqui, SM, Macedo, TS, Moreira, DRM, Leite, ACL, Soares, MBP, et al.. Design, synthesis and biologicalevaluation of 3-[4-(7-chloro-quinolin-4-yl)-piperazin-1-yl]-propionic acid hydrazones as antiprotozoal agents. Eur J Med Chem 2014;75:67–76. https://doi.org/10.1016/j.ejmech.2014.01.023.Search in Google Scholar PubMed

21. Gemma, S, Kukreja, G, Fattorusso, C, Persico, M, Romano, MP, Altarelli, M, et al.. Synthesis of N1-arylidene-N2-quinolyl-and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains. Bioorg Med Chem Lett 2006;16:5384–8. https://doi.org/10.1016/j.bmcl.2006.07.060.Search in Google Scholar PubMed

22. Aslanhan, Ö, Kalay, E, Tokalı, FS, Can, Z, Şahin, E. Design, synthesis, antioxidant and anticholinesterase activities of novel isonicotinic hydrazide-hydrazone derivatives. J Mol Struct 2023:135037. https://doi.org/10.1016/j.molstruc.2023.135037.Search in Google Scholar

23. Terzioglu, N, Gürsoy, A. Synthesis and anticancer evaluation of some new hydrazone derivatives of 2, 6-dimethylimidazo [2,1-b] [1,3,4] thiadiazole-5-carbohydrazide. Eur J Med Chem 2003;38:781–6. https://doi.org/10.1016/s0223-5234(03)00138-7.Search in Google Scholar PubMed

24. Oderinlo, O, Jordaan, A, Seldon, R, Isaacs, M, Hoppe, H, Warner, DF, et al.. Novel hydrazone-tethered 5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol hybrids: synthesis, characterisation, in silico ADME studies and in vitro antimycobacterial evaluation. ChemMedChem 2023;18:e202200572. https://doi.org/10.1002/cmdc.202200572.Search in Google Scholar PubMed

25. Ayşen, I, Çevik, UA, Çelik, I, Bostancı, HE, Karayel, A, Gündoğdu, G, et al.. Benzimidazole-hydrazone derivatives: synthesis, in vitro anticancer, antimicrobial, antioxidant activities, in silico DFT and ADMET studies. J Mol Struct 2022;1270:133946. https://doi.org/10.1016/j.molstruc.2022.133946.Search in Google Scholar

26. Tapera, M, Kekeçmuhammed, H, Tüzün, B, Sarıpınar, E, Koçyiğit, ÜM, Yıldırım, E, et al.. Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular docking studies of new imidazolyl hydrazone derivatives. J Mol Struct 2022;1269:133816. https://doi.org/10.1016/j.molstruc.2022.133816.Search in Google Scholar

27. SMART, Bruker AXS, 2000.Search in Google Scholar

28. Dolomanov, OV, Bourhis, LJ, Gildea, RJ, Howard, JAK, Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J Appl Crystallogr 2009;42:339–41. https://doi.org/10.1107/s0021889808042726.Search in Google Scholar

29. Sheldrick, GM. SHELXT-integrated space-group and crystal-structure determination. Acta Cryst 2015;A71. https://doi.org/10.1107/s2053273314026370.Search in Google Scholar

30. Macrae, CF, Edgington, PR, McCabe, P, Pidcock, E, Shields, GP, Taylor, R, et al.. Mercury: visualization and analysis of crystal structures. J Appl Crystallogr 2006;39:453–7. https://doi.org/10.1107/s002188980600731x.Search in Google Scholar

31. Gezegen, H, Gürdere, MB, Dinçer, A, Özbek, O, Koçyiğit, ÜM, Taslimi, P, et al.. Synthesis, molecular docking, and biological activities of new cyanopyridine derivatives containing phenylurea. Arch Pharm 2021;354:2000334. https://doi.org/10.1002/ardp.202000334.Search in Google Scholar PubMed

32. Verpoorte, JA, Mehta, S, Edsall, JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem 1967;242:4221–9. https://doi.org/10.1016/s0021-9258(18)95800-x.Search in Google Scholar

33. Armstrong, DD. Subchapter S--Its opportunities and pitfalls. N Y Certif Public Accountant (pre-1986) 1966;36:573.Search in Google Scholar

34. Kocyigit, UM, Taşkıran, AŞ, Taslimi, P, Yokuş, A, Temel, Y, Gulçin, İ. Inhibitory effects of oxytocin and oxytocin receptor antagonist atosiban on the activities of carbonic anhydrase and acetylcholinesterase enzymes in the liver and kidney tissues of rats. J Biochem Mol Toxicol 2017;31:e21972. https://doi.org/10.1002/jbt.21972.Search in Google Scholar PubMed

35. Koçyiğit, ÜM, Doğan, M, Muğlu, H, Taslimi, P, Tüzün, B, Yakan, H, et al.. Determination of biological studies and molecular docking calculations of isatin-thiosemicarbazone hybrid compounds. J Mol Struct 2022;1264:133249. https://doi.org/10.1016/j.molstruc.2022.133249.Search in Google Scholar

36. Doğan, M, Koçyiğit, ÜM, Gürdere, MB, Ceylan, M, Budak, Y. Synthesis and biological evaluation of thiosemicarbazone derivatives. Med Oncol 2022;39:157. https://doi.org/10.1007/s12032-022-01784-y.Search in Google Scholar PubMed

37. Koçyiğit, ÜM, Taslimi, P, Tüzün, B, Yakan, H, Muğlu, H, Güzel, E. 1,2,3-Triazole substituted phthalocyanine metal complexes as potential inhibitors for anticholinesterase and antidiabetic enzymes with molecular docking studies. J Biomol Struct Dyn 2022;40:4429–39. https://doi.org/10.1080/07391102.2020.1857842.Search in Google Scholar PubMed

38. Güzel, E, Koçyiğit, ÜM, Taslimi, P, Gülçin, İ, Erkan, S, Nebioğlu, M, et al.. Phthalocyanine complexes with (4-isopropylbenzyl) oxy substituents: preparation and evaluation of anti-carbonic anhydrase, anticholinesterase enzymes and molecular docking studies. J Biomol Struct Dyn 2022;40:733–41. https://doi.org/10.1080/07391102.2020.1818623.Search in Google Scholar PubMed

39. Schrödinger release 2021-3: Maestro, Schrödinger, LLC, New York, NY, 2021.Search in Google Scholar

40. Schrödinger release 2021-3: protein preparation wizard; Epik, Schrödinger, LLC, New York, NY, 2021; Impact, Schrödinger, LLC, New York, NY; Prime, Schrödinger, LLC, New York, NY, 2021.Search in Google Scholar

41. Schrödinger release 2021-3: LigPrep, Schrödinger, LLC, New York, NY, 2021.Search in Google Scholar

42. Shahzadi, I, Zahoor, AF, Tüzün, B, Mansha, A, Anjum, MN, Rasul, A, et al.. Repositioning of acefylline as anti-cancer drug: synthesis, anticancer and computational studies of azomethines derived from acefylline tethered 4-amino-3-mercapto-1,2,4-triazole. PLoS One 2022;17:e0278027. https://doi.org/10.1371/journal.pone.0278027.Search in Google Scholar PubMed PubMed Central

43. Schrödinger release 2021-3: QikProp, Schrödinger, LLC, New York, NY, 2021.Search in Google Scholar

44. Gao, BB, Clermont, A, Rook, S, Fonda, SJ, Srinivasan, VJ, Wojtkowski, M, et al.. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med 2007;13:181–8. https://doi.org/10.1038/nm1534.Search in Google Scholar PubMed

45. Supuran, CT. Carbonic anhydrases-an overview. Curr Pharma Des 2008;14:603–14. https://doi.org/10.2174/138161208783877884.Search in Google Scholar PubMed

46. Tuzun, B, Taş, NA, Taslimi, P, Karadağ, A. Synthesis, enzyme inhibition, and in silico studies of amino acid schiff bases. Iran J Chem Chem Eng 2024;43:1083–93.Search in Google Scholar

47. Tapera, M, Kekeçmuhammed, H, Sarıpınar, E, Doğan, M, Tüzün, B, Koçyiğit, ÜM, et al.. Molecular hybrids integrated with imidazole and hydrazone structural motifs: design, synthesis, biological evaluation, and molecular docking studies. J Mol Liq 2023;391:123242. https://doi.org/10.1016/j.molliq.2023.123242.Search in Google Scholar

48. Manap, S, Medetalibeyoğlu, H, Kılıç, A, Karataş, OF, Tüzün, B, Alkan, M, et al.. Synthesis, molecular modeling investigation, molecular dynamic and ADME prediction of some novel Mannich bases derived from 1, 2, 4-triazole, and assessment of their anticancer activity. J Biomol Struct Dyn 2024;42:11916–30. https://doi.org/10.1080/07391102.2023.2265501.Search in Google Scholar PubMed

49. Durmaz, L, Gulçin, İ, Taslimi, P, Tüzün, B. Isofraxidin: antioxidant, anti-carbonic anhydrase, anti-cholinesterase, anti-diabetic, and in silico properties. ChemistrySelect 2023;8:e202300170. https://doi.org/10.1002/slct.202300170.Search in Google Scholar

50. Aksu, A, Çelik, MS, Polat, ZA, Yenidünya, AF, Tuzun, B. Experimental and theoretical evidence on the amoebicidal activity of synthesized tRNA-palmitic acid esters. Iran J Chem Chem Eng 2024;43:695–706.Search in Google Scholar

51. Tokalı, FS, Taslimi, P, Tuzun, B, Karakuş, A, Sadeghian, N, Gulçin, İ. Novel quinazolinone derivatives: synthetic analogues for the treatment of glaucoma, alzheimer’s disease and diabetes mellitus. Chem Biodiver 2023;20:e202301134. https://doi.org/10.1002/cbdv.202301134.Search in Google Scholar PubMed

52. Majumdar, D, Philip, JE, Tüzün, B, Roy, S. Synthesis, characterization, crystallographic aspects, Fukui function, and photodynamic antifungal chemotherapy investigation of Cd (II)-tricyanomethanide coordination polymer: insights from DFT. Inorg Chem Commun 2023;155:111057. https://doi.org/10.1016/j.inoche.2023.111057.Search in Google Scholar

53. Yuriy, K, Kusdemir, G, Volodymyr, P, Tüzün, B, Taslimi, P, Karatas, OF, et al.. biochemistry-oriented drug design: synthesis, anticancer activity, enzymes inhibition, molecular docking studies of novel 1,2,4-triazole derivatives. J Biomol Struct Dyn 2024;42:1220–36. https://doi.org/10.1080/07391102.2023.2253906.Search in Google Scholar PubMed

54. Tokalı, FS, Taslimi, P, Tüzün, B, Karakuş, A, Sadeghian, N, Gulçin, İ. Synthesis of new carboxylates and sulfonates containing thiazolidin-4-one ring and evaluation of inhibitory properties against some metabolic enzymes. J Iran Chem Soc 2023;20:2631–46. https://doi.org/10.1007/s13738-023-02861-3.Search in Google Scholar

55. Hermi, S, Mrad, MH, Alotaibi, AA, Tüzün, B, Böhme, U, Alotaibi, KM, et al.. A new 1-D polymeric chains of (C5H6ClN2)[CdCl3H2O]. H2O perovskite: synthesis, Structure, Physico-Chemical Characteristics, theoretical calculations, and biological effects. Inorg Chem Commun 2023;155:111122.10.1016/j.inoche.2023.111122Search in Google Scholar

56. Mermer, A, Tüzün, B, Daştan, SD, Koçyiğit, ÜM, Çetin, FN, Çevik, Ö. Piperazin incorporated Schiff Base derivatives: assessment of in vitro biological activities, metabolic enzyme inhibition properties, and molecular docking calculations. J Biochem Mol Toxicol 2023;37:e23465. https://doi.org/10.1002/jbt.23465.Search in Google Scholar PubMed

57. Çelik, MS, Kütük, N, Yenidünya, AF, Çetinkaya, S, Tüzün, B. Removal of safranin O from wastewater using Streptomyces griseobrunneus dead biomass and in silico calculations. Biomass Convers Bior 2024;14:25873–84. https://doi.org/10.1007/s13399-023-04558-2.Search in Google Scholar

58. Lipinski, CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004;1:337–41. https://doi.org/10.1016/j.ddtec.2004.11.007.Search in Google Scholar PubMed

59. Lipinski, CA, Lombardo, F, Dominy, BW, Feeney, PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3–25. https://doi.org/10.1016/s0169-409x(96)00423-1.Search in Google Scholar

60. Jorgensen, WJ, Duffy, EM. Prediction of drug solubility from structure. Adv Drug Deliv Rev 2002;54:355–66. https://doi.org/10.1016/s0169-409x(02)00008-x.Search in Google Scholar PubMed


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/znc-2024-0226).


Received: 2024-10-15
Accepted: 2025-02-17
Published Online: 2025-03-14

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/znc-2024-0226/html
Scroll to top button